News

The terms of the agreement include national distribution of GenomicsRX DNA Personalized Genetics Analysis Kits into a network of more than 1000 spas and medspas across the country.

The study is intended to assess the safety and efficacy of SML’s experimental drug product, brostallicin. The trial will also be supported by the Sarcoma Foundation of America

In the collaboration, Pepscan will use its proprietary Clips technology to identify functional mimics of the essential parts of intractable targets. These mimics will be used by Genmab

This approval marks the first time Smith & Nephew’s technology will be available in the world’s second largest orthopaedic market. The Genesis II knee system will be the

The pivotal trial will be a multi-center, prospective, non-randomized study of 140 patients and will include up to 40 centers. The DuraHeart LVAS is a third generation circulatory

In this ruling, the Court found that the patent at issue was invalid, because it was obvious. Yasmin (drospirenone and ethinyl estradiol) provides an oral contraceptive regimen consisting

In important tests against a difficult-to-treat strain of human colon cancer cells (HCT116), scientists evaluated the performance of concentrated amounts of company’s newest anticancer compounds. Researchers observed a

Under the terms of the agreement, Vermillion is granted exclusive rights to the biomarker panel, and will undertake the development and commercialization of a PAD blood test, which

If, as anticipated, ABI’s new study demonstrates the efficacy and safety of this treatment regimen, ABI intends to conduct a Phase III study before filing a marketing approval